Literature DB >> 17565638

Predicting pleural effusion and ascites following extended hepatectomy in the non-cirrhotic liver.

Yasuhiro Shimizu1, Tsuyoshi Sano, Kenzo Yasui.   

Abstract

BACKGROUND: There are cases in which intractable pleural effusion and/or ascites appear even in the non-cirrhotic liver following extended liver resection, making postoperative management difficult. In this study we investigated the risk factors for pleural effusion and ascites following extended hepatectomy.
METHODS: Subjects were 50 patients between 1996 and 2003 who had hepatic metastasis of colorectal cancer, and who underwent extended liver resection of hemihepatectomy or greater at a time separate from the surgery for their colorectal cancer. The 50 patients were classified according to the presence or absence of pleural effusion and/or ascites, and compared for preoperative ICGR15, pre- and postoperative total serum protein and albumin levels, operating time, amount of blood loss, resected liver weight g/bodyweight kg (Hx ratio), intraoperative fluid replacement volume, period of surgery, operative procedure, use of serum and plasma derivatives, and use of catecholamines.
RESULTS: In a univariate analysis of pleural effusion and ascites, the Hx ratio, period of surgery, operative procedure, use of fresh frozen plasma and use of albumin preparations were significant factors, but in a multivariate analysis only the Hx ratio was a significant independent factor. Among patients with an Hx ratio of 8 or above, many had postoperative pleural effusion and ascites.
CONCLUSIONS: The Hx ratio is a simple method for the evaluation of postoperative remnant liver function and is extremely useful as a predictive factor for pleural effusion and ascites following extended hepatectomy in the non-cirrhotic liver.

Entities:  

Mesh:

Year:  2007        PMID: 17565638     DOI: 10.1111/j.1440-1746.2007.04872.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  7 in total

1.  Initial 12-h operative fluid volume is an independent risk factor for pleural effusion after hepatectomy.

Authors:  Xiang Cheng; Jia-Wei Wu; Ping Sun; Zi-Fang Song; Qi-Chang Zheng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-12-07

2.  Validation of biological and clinical outcome between with and without thoracotomy in liver resection: a matched cohort study.

Authors:  Shintaro Yamazaki; Tadatoshi Takayama; Masamichi Moriguchi; Shunji Okada; Yuki Hayashi; Hisashi Nakayama; Tokio Higaki; Masahiko Sugitani
Journal:  World J Surg       Date:  2012-01       Impact factor: 3.352

Review 3.  A review of factors predicting perioperative death and early outcome in hepatopancreaticobiliary cancer surgery.

Authors:  Chris D Mann; Tom Palser; Chris D Briggs; Iain Cameron; Myrrdin Rees; John Buckles; David P Berry
Journal:  HPB (Oxford)       Date:  2010-08       Impact factor: 3.647

4.  MELD-sodium score and its prognostic value in malignancy-related ascites of pancreatic and gastric cancer.

Authors:  Hüseyin Engin; Cemil Bilir; Yücel Ustündağ
Journal:  Support Care Cancer       Date:  2012-10-27       Impact factor: 3.603

5.  Does Intermittent Pringle Maneuver Increase Postoperative Complications After Hepatectomy for Hepatocellular Carcinoma? A Randomized Controlled Trial.

Authors:  Kit Fai Lee; John Wong; Sunny Y S Cheung; Charing C N Chong; Joyce W Y Hui; Vivian Y F Leung; Simon C H Yu; Paul B S Lai
Journal:  World J Surg       Date:  2018-10       Impact factor: 3.352

6.  Predictive model for postoperative pleural effusion after hepatectomy.

Authors:  Hidetoshi Nitta; Chisho Mitsuura; Yuta Shiraishi; Tatsunori Miyata; Kenji Shimizu; Kazuto Harada; Ryuichi Karashima; Toshiro Masuda; Katsutaka Matsumoto; Tetsuya Okino; Yo-Ichi Yamashita; Hideo Baba; Hiroshi Takamori
Journal:  Ann Gastroenterol Surg       Date:  2020-12-17

7.  Neutrophil Elastase Inhibitor Following Liver Resection: A Matched Cohort Study.

Authors:  Shintaro Yamazaki; Tadatoshi Takayama; Masamichi Moriguchi; Yuki Hayashi; Yusuke Mitsuka; Nao Yoshida; Tokio Higaki
Journal:  Hepat Mon       Date:  2015-11-07       Impact factor: 0.660

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.